Psigryph Inc.
PrivateLast Round
Accelerator
Nov 3, 2024
Total Funding Raised
$123,000
Company Overview
Psigryph Inc. is a biotechnology company that develops a patented, plant-derived nanodelivery system called Nanopect™ to enhance the bioavailability of bioactive molecules across cell membranes for applications in agriculture, food, and pharmaceuticals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Sustainable Materials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Psigryph Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Psigryph Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Nov 3, 2024 | ||||
| Grant | Aug 29, 2022 | ||||
| Grant | Aug 4, 2022 | ||||
| Accelerator | May 18, 2022 |
Key People
Founding team and executive leadership
Psigryph Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HudsonAlpha Institute for Biotechnology | Accelerator |
| Sustainable Development Technology Canada | Grant |
| gener8tor | Accelerator |
| i.d.e.a. Fund | Grant |
| MassChallenge Switzerland | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 3, 2024
$100K raised from gener8tor and HudsonAlpha Institute.
- May 18, 2022
Received funding from MassChallenge Switzerland.
Psigryph Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Psigryph Inc.'s valuation, stock price, and market status.